Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

0.904
Delayed Data
As of Mar 27
 -0.026 / -2.80%
Today’s Change
0.51
Today|||52-Week Range
3.87
+29.16%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close0.93
Today’s open0.93
Day’s range0.90 - 0.93
Volume216,593
Average volume (3 months)1,091,774
Market cap$32.0M
Dividend yield--
Data as of 4:00pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+23.81%
Earnings growth (this year)+25.78%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,471.01%
P/E ratioNM
Price/Sales56.21
Price/Book0.64

Competitors

 Today’s
change
Today’s
% change
BGMDBG Medicine Inc+0.07+8.15%
ECTEEcho Therapeutics In...-0.19-7.13%
BIODBiodel Inc-0.04-3.28%
SKBISkystar Bio-Pharmace...+0.03+0.75%
Data as of 4:00pm ET, 03/27/2015

Financials

Last reporting dateMarch 24, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$1.1M
Annual profit (last year)-$10.2M
Net profit margin-941.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account